Skip to content
Screener

Alkermes ALKS Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

AbbVie logo
AbbVieABBV
$7.99B+100%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$489M
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$0
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.11B+85.1%
Enterprise value$9.18B+133%
P/E122.7×+110×
P/S4.9×+2.0×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfDebt.

The source filing: Alkermes’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:30 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206534
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
Cash flows (used in) provided by investing activities(2,077,000)9,102
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of ordinary shares under share-based compensation arrangements15,71429,528
Proceeds from the issuance of debt, net1,511,557
Deferred financing costs paid to third-parties(1,614)
Employee taxes paid related to net share settlement of equity awards(23,442)(28,781)
Payment for the repurchase of ordinary shares(27,696)
Cash flows provided by financing activities1,474,519747

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's debt issuance proceeds?
Alkermes (ALKS) reported debt issuance proceeds of $1.51B in Q1 2026.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.

Ask your AI about Alkermes's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude